Sign in Sign up for free

Navidea Biopharmaceuticals Inc Gross margin

What is the Gross margin of Navidea Biopharmaceuticals Inc?

The Gross margin of Navidea Biopharmaceuticals Inc is 97.04%

What is the definition of Gross margin?



Gross margin is the difference between revenue and cost of goods sold, divided by revenue, and expressed as a percentage.

lfy (last fiscal year)

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Gross margin of companies in the Health Care sector on NYSEMKT compared to Navidea Biopharmaceuticals Inc

What does Navidea Biopharmaceuticals Inc do?

navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de

Companies with gross margin similar to Navidea Biopharmaceuticals Inc